|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||173.01 - 178.90|
|52-week range||77.72 - 184.00|
|PE ratio (TTM)||38.57|
|Earnings date||20 Feb 2018 - 23 Feb 2018|
|Forward dividend & yield||0.00 (0.00%)|
|1y target est||170.00|
Rogers Corporation today announced President and CEO, Bruce Hoechner, and Senior Vice President and CFO, Janice Stipp, will be presenting at the Needham Growth Conference in New York City on Wednesday January 17 at 10:00 am EST.
Zacks.com highlights: Jones Lang LaSalle, Rogers, PBF Energy, Westlake Chemical and DXC Technology
Rogers Corporation today announced Senior Vice President and CTO, Bob Daigle, and Senior Vice President and CFO, Janice Stipp, will be presenting at the Baird Global Industrial Conference in Chicago on Wednesday November 8 at 9:30 am CST.
The Chandler, Arizona-based company said it had net income of $1.37 per share. Earnings, adjusted for non-recurring costs, came to $1.41 per share. The specialty materials company posted revenue of $206.8 ...
Rogers Corporation plans to announce third quarter 2017 results on November 2 after market close, which will be followed by a conference call at 5pm ET. The call will be hosted by Bruce Hoechner, President and CEO, who will be joined by Janice Stipp, SVP and CFO, and Bob Daigle, SVP and CTO.
The search for an Alzheimer's disease treatment has been unsuccessful for the past 14 years...
AstraZeneca shares fell 15 percent after disappointing results for a lung cancer treatment in highly anticipated clinical trial.
Europe's largest oil firm Royal Dutch Shell has beaten analyst expectations, reporting profits for its second quarter that are three times larger than this time last year.
Socially responsible investing may not beat traditional stock market funds, but SRI funds are generating performance that's just as good.
Roche-backed Foundation Medicine will bring its genomic sequencing of tumors to China in the third quarter.
A new technology startup called Genome Medical has a plan to address the shortage of genetic counselors.
ASCO's abstract drop reveals the progress being made in attacking cancer and, inevitably, moves stocks both large and small.
Roche remains committed to the U.S. despite President Donald Trump's pledges to crackdown on pharmaceutical companies "getting away with murder."